Top FDA regulator unapologetic on his about-face; mass layoffs at a San Diego biotech raise questions

Taking stock of the drug industry, from the lab to the medicine chest  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: 'I have a right to change my mind': A top FDA regulator is unapologetic over his about-face on Chinese cancer drugs By Adam Feuerstein FDA/Michael J. Ermarth In an interview with STAT, the FDA's Richard Pazdur acknowledged his view on Chinese cancer drugs had changed. Read More STAT+: The unexpected forces behind thousands of comments about Medicare's limits on a new Alzheimer's drug By Nicholas Florko Adobe Medicare has gotten thousands of comments on its proposal to limit coverage for Aduhelm. But most aren’t from drug makers. Read More STAT+: A San Diego biotech's massive valuation turned heads. Now, mass layoffs raise questions By Jonathan Wosen and Matthew Herper Jonathan Wosen/STAT The layoffs could be seen as yet another reality check for the outsized bets made by some investors on privately held biotechnology firms. Read More Sponsor content by SUFFOLK UNIVERSITY BOSTON Pharma at the intersection of private enterprise and public interest The pharmaceutical industry is global, highly competitive, and tightly regulated. As its challenges and opportunities grow, so does its need for professionals who fully understand the legal, business, and scientific considerations involved in the drug development process. Tomorrow's pharma leaders can gain that expertise with a Master of Science in Law: Life Sciences. A no good, very bad week for Biden's science agenda By Nicholas Florko Alex Hogan/STAT D.C. Diagnosis is STAT's weekly newsletter about the politics and policy of health and medicine. Sign up to get it in your inbox. Read More Tuesday, February 8, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser